Risk-Based Audit Planning in Pharmacovigilance
- Risk-Based Audit Planning in Pharmacovigilance
- Introduction
- What Is Risk-Based Audit Planning?
- Why Risk-Based Planning Matters
- Regulatory Expectations
- Understanding Risk in Pharmacovigilance
- Risk Assessment Inputs
- The Audit Universe
- Risk Scoring Models
- Common High-Risk Areas
- Audit Frequency and Risk
- Dynamic Risk Assessment
- Vendor Risk and Audit Planning
- QPPV Input into Audit Planning
- Inspection Perspective
- Common Planning Failures
- Characteristics of Mature Risk-Based Planning
- Key Takeaways
- References
Introduction
Every pharmacovigilance system contains more auditable activities than available audit resources.
Potential audit targets may include:
- Case processing
- Literature surveillance
- Signal management
- Aggregate reporting
- Risk management systems
- Vendors
- Affiliates
- Safety databases
- QPPV oversight processes
- Quality systems
Attempting to audit everything equally is rarely practical.
Modern pharmacovigilance audit programmes therefore rely upon risk-based planning.
Risk-based planning helps organisations focus audit resources where assurance is needed most.
What Is Risk-Based Audit Planning?
Risk-based audit planning is the process of prioritising audit activities according to risk.
Rather than asking:
What can we audit?
The organisation asks:
What should we audit?
The objective is to direct audit attention toward areas where failures would have the greatest consequences.
Why Risk-Based Planning Matters
Resources are always limited.
Audit teams face constraints involving:
- Time
- Personnel
- Budget
- Expertise
Risk-based planning helps ensure those resources produce maximum value.
Benefits include:
- Better assurance
- Better resource allocation
- Better inspection readiness
- Better risk management
- Better governance visibility
Regulatory Expectations
Regulators generally expect audit programmes to be risk-based.
Inspectors may review:
- Risk assessment methodologies
- Audit plans
- Audit justifications
- Audit frequencies
The key question is often:
Can the organisation explain why certain activities were audited and others were not?
Risk-based planning provides that rationale.
Understanding Risk in Pharmacovigilance
Risk can be viewed through several lenses.
Patient Safety Risk
Could failure affect patient safety?
Regulatory Risk
Could failure create non-compliance?
Operational Risk
Could failure disrupt pharmacovigilance activities?
Reputational Risk
Could failure damage organisational credibility?
Data Integrity Risk
Could safety data become inaccurate, incomplete or unavailable?
These dimensions help determine audit priorities.
Risk Assessment Inputs
Several information sources may support planning.
Previous Audit Results
Past findings often predict future risk.
Inspection Findings
Regulatory observations may highlight vulnerabilities.
KPI Trends
Performance deterioration may indicate emerging concerns.
CAPA Performance
Repeated CAPA failures may suggest systemic weaknesses.
Significant Deviations
Major deviations frequently warrant additional attention.
Organisational Changes
Structural changes may increase uncertainty.
The strongest plans use multiple data sources.
The Audit Universe
Risk-based planning begins with the audit universe.
The audit universe represents all auditable activities.
Examples include:
Core PV Activities
- ICSR management
- Signal management
- Aggregate reporting
Governance Activities
- QPPV oversight
- Escalation processes
Vendor Activities
- Outsourced services
- Technology providers
Quality Activities
- CAPAs
- Training
- Deviations
Every activity within the universe should be capable of risk assessment.
Risk Scoring Models
Many organisations use structured scoring approaches.
Example:
| Risk Factor | Score |
|---|---|
| Patient Safety Impact | 1–5 |
| Regulatory Impact | 1–5 |
| Complexity | 1–5 |
| Change Exposure | 1–5 |
| Historical Performance | 1–5 |
Higher scores generally indicate higher audit priority.
The exact methodology is less important than consistency.
Common High-Risk Areas
Certain areas frequently receive greater audit attention.
Case Processing
Direct impact on reporting compliance.
Signal Management
Direct impact on benefit-risk monitoring.
Aggregate Reporting
Critical regulatory obligation.
Critical Vendors
Outsourced activities with significant dependency.
Safety Databases
High data integrity importance.
Major Organisational Changes
Periods of elevated uncertainty.
These areas are often considered audit priorities.
Audit Frequency and Risk
Risk frequently influences audit frequency.
Example:
| Risk Level | Typical Approach |
|---|---|
| Low | Longer intervals |
| Medium | Periodic review |
| High | Frequent audits |
| Critical | Enhanced oversight |
The principle is straightforward:
Higher risk generally warrants greater assurance.
Dynamic Risk Assessment
Risk is not static.
Examples of changing risk include:
- New products
- New vendors
- Acquisitions
- Regulatory changes
- Technology migrations
Audit plans should therefore remain flexible.
An annual plan should not prevent response to emerging risks.
Vendor Risk and Audit Planning
Vendor audits are frequently risk-driven.
Questions may include:
- Is the vendor critical?
- Has performance deteriorated?
- Have significant findings occurred?
- Is organisational dependency increasing?
Risk assessment helps determine audit priorities.
For additional discussion see:
[[vendor-risk-assessment]]
[[critical-vendor-management]]
QPPV Input into Audit Planning
The QPPV can provide valuable insight regarding:
- Emerging risks
- Compliance concerns
- Regulatory priorities
- Vendor oversight concerns
Although the QPPV may not own the audit programme, their perspective can strengthen planning significantly.
Inspection Perspective
Inspectors frequently review whether audit plans reflect organisational risks.
Common questions include:
- Why was this area selected?
- Why was this area excluded?
- How was risk assessed?
- How are changes managed?
Strong risk-based planning provides defensible answers.
Common Planning Failures
Several weaknesses occur repeatedly.
Equal Treatment of All Activities
Resources become diluted.
Static Risk Assessments
Plans fail to adapt.
Weak Documentation
Priorities cannot be explained.
Over-Reliance on Historical Schedules
Previous plans drive future plans without reassessment.
Ignoring Emerging Risks
New threats remain unaudited.
These weaknesses reduce assurance significantly.
Characteristics of Mature Risk-Based Planning
High-performing organisations generally demonstrate:
Structured Risk Assessment
Methodologies are documented.
Multiple Information Sources
Decisions are evidence-based.
Dynamic Planning
Plans can evolve.
Governance Integration
Risk information influences priorities.
QPPV Visibility
Important risks remain visible.
Inspection Readiness
Planning rationales are defendable.
These characteristics strengthen audit effectiveness considerably.
Key Takeaways
- Risk-based planning directs audit resources toward areas of greatest importance.
- Risk assessment should consider patient safety, compliance, operational and data integrity impacts.
- Audit universes provide the foundation for planning.
- Audit frequency should generally reflect risk.
- Risk assessments should be reviewed periodically.
- Vendor risks and organisational changes should influence priorities.
- Inspectors frequently evaluate planning rationales.
- Mature audit programmes use dynamic, evidence-based planning approaches.
References
- EMA Good Pharmacovigilance Practices (GVP) Module IV – Pharmacovigilance Audits.
- EMA Good Pharmacovigilance Practices (GVP) Module I – Pharmacovigilance Systems and Their Quality Systems.
- EMA Good Pharmacovigilance Practices (GVP) Module III – Pharmacovigilance Inspections.
- Regulation (EC) No 726/2004.
- Directive 2001/83/EC.
- Commission Implementing Regulation (EU) No 520/2012.
- ICH Q9 Quality Risk Management.
- ICH E2E Pharmacovigilance Planning.